Codexis, Inc. is a company in the U.S. stock market and it is a holding in 45 U.S.-traded ETFs. CDXS has around 10.2M shares in the U.S. ETF market. The largest ETF holder of CDXS is the ARK Genomic Revolution ETF (ARKG), with approximately 6.43M shares. Investors may also find of interest that the ETF with the largest allocation to CDXS stock is Jacob Forward ETF (JFWD), with a portfolio weight of 5.84%. On average, U.S. ETFs allocate 0.29% of CDXS to their portfolios.
Additionally, CDXS is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CDXS as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.